Recurrent osteosarcoma of maxilla presenting as fungating mass: A case report

Introduction: Osteosarcoma is the most common primary malignant bone tumor excluding hematopoietic neoplasms. It is thought to arise from a primitive mesenchymal bone-forming cell and is characterized by production of osteoid. Despite osteosarcomas of the jaws being less aggressive than those occurring in the long bones, local recurrence after surgical therapy is a major complication. Case Report: We report a case of recurrent osteosarcoma of maxilla, within three years after surgical resection presenting as a rapidly growing fungating mass in a 24-year-old female. Conclusion: Osteosarcoma affecting the maxilla is a relatively rare condition when compared to the long bones. Early diagnosis and treatment can improve the survival rate. Management of super added fungal infections associated with chemoradiotherapy can prevent further complications and improve the general health of the patient in recurrent lesions. (This page in not part of the published article.) International Journal of Case Reports and Images, Vol. 7 No. 3, March 2016. ISSN – [0976-3198] Int J Case Rep Images 2016;7(3):149–153. www.ijcasereportsandimages.com Sivakumar et al. 149 CASE REPORT OPEN ACCESS Recurrent osteosarcoma of maxilla presenting as fungating mass: A case report T. T. Sivakumar, Pratheep Jeevadhas, Varun B. Raghavanpillai, Subramonian Sivaraj, Anna P. Joseph, Saira E. Denny


INtrODUctION
Osteosarcomas of the jaws are uncommon and represent 6-8% of all osteosarcomas [1]. It occurs most often in the third and fourth decades of life, with the mean age being 33 years. As in the long bones a slight male predominance is noted in gnathic osteosarcomas. The maxilla and mandible are involved with about equal frequency. Maxillary lesions are seen commonly involving the inferior portion (alveolar ridge, sinus floor, palate) than the superior aspects (zygoma, orbit) [2]. Although it is generally believed that osteosarcoma of the jaws is less aggressive than those of the long bones, current clinicopathological studies suggest that osteosarcomas of the jaws are aggressive neoplasms. The ability to achieve initial complete removal of the lesion with clear surgical margins of greater than 5 mm is said to demonstrate a better survival, fewer local recurrences, and less metastasis [3]. Osteosarcomas arising from the maxilla are often more difficult to resect completely than mandibular lesions reflecting in a relatively high recurrence rate [4,5]. Here we present a diagnostically challenging case of osteosarcoma with a unique clinical presentation.

cAsE rEPOrt
A 24-year-old female reported to the clinic with the chief complaint of a large swelling on the right side of face. She also complained of foul smell, inability to open mouth and multiple ulcers over the swelling. History revealed that the patient developed a right maxillary swelling two years back for which an intra-oral incisional biopsy was performed. The lesion was then given a diagnosis of osteosarcoma. The patient was treated with hemimaxillectomy and chemotherapy with adriamycin 90 mg and ifosfamide 3000 mg, with addition of cisplatin 60 mg to the regimen on the second cycle. She received postoperative adjuvant radiotherapy of 60 Gy/30# by IMRT using 6 MV over a span of one month and nine days. Presently, the patient reported to the clinic with a swelling in the same region which rapidly increased in size. On examination, a large extra oral swelling involving the entire right side of face with multiple superficial polypoid masses was seen. The overlying skin appeared dark and erythematous, with polypoid masses exhibiting superficial ulcerations. Intraoral examination revealed huge mass involving the entire oral cavity with necrotic areas causing dysphonia and dysphagia ( Figure 1).
Radiographically, anterioposterior view showed right hemimaxillectomy and a mixed radiolucentradiopaque lesion with ill-defined borders ( Figure 2). Computed tomography scan revealed large infiltrating heterogeneous isodense mass with areas of cystic density and hemorrhagic foci. The lesion was causing erosion of the right side of the facial structures involving lateral wall of orbit, zygomatic arch, ethmoid sinus, hard palate. The lesion was extending to the right aspect of nose displacing nasal septum to left and was protruding into oral cavity. Right submental enlarged lymph node of size 1x10.9 cm was observed. Tc 99m -MDP bone scan revealed an abnormal increased radiotracer uptake in the right maxillary bone and rest of the skeletal system appeared normal.
An incisional biopsy was performed from the intraoral lesion and was sent for histopathological examination. Microscopic examination revealed numerous fungal hyphae and spores along with large areas of necrotic debri ( Figure 3). A repeat biopsy after antifungal therapy was performed. The histopathology revealed numerous ovoid to polygonal neoplastic cells showing nuclear pleomorphism with increased mitosis. Osteoid formation ( Figure 4) and with associated tumor giant cells were noticed within the stroma and the lesion was diagnosed as high grade recurrent osteosarcoma ( Figure 5).
The patient was put on chemotherapy with doxyrubicin (60 mg), ifosfamide (3000 mg), methotrexate (12 mg) and cisplatin (60 mg). The patient expired during course of the treatment.

DIscUssION
Osteosarcomas are malignant connective tissue tumors originating from undifferentiated mesenchymal cells that are able to form bone or osteoid tissue. It can occur in any bone, the most common site being the long bones of the extremities near metaphyseal growth plate. Osteosarcomas of the craniofacial region are relatively rare. Although mandible is reported as the most common site of involvement in the craniofacial region, equal frequencies of maxillary osteosarcomas have also been reported [6]. Mean age of onset of osteosarcomas of craniofacial region is in the third to fourth decade of life. There is usually a predilection for occurrence in males. However, some author report it to be more frequent in females or with an equal gender predilection [6].
Although it is generally believed that osteosarcoma of the jaws is less aggressive than those of the long bones, current clinicopathological studies suggest that osteosarcomas of the jaws are aggressive neoplasms. Our case is an example of such an aggressive neoplasm in the maxilla. The multiple large polypoid masses seen on the surface of the lesion were unique to our case. These superficial masses were due to the secondary infection by opportunistic fungi. The patient's compromised immune status due to the previous chemotherapy and radiotherapy could have contributed to the fungal infection, which in turn can cause serious morbidity and mortality. The radiographic appearance of osteosarcoma is variable ranging from osteolytic to mixed osteolyticosteoblastic to predominantly osteoblastic lesions [7]. It depends on the amount of tumor bone synthesized by the malignant osteoblasts. Our case showed mixed radiolucent -radiopacity with ill-defined borders.
The common histological types of osteosarcomas are chondroblastic, osteoblastic and fibroblastic. The typical histological criteria for the diagnosis of a high grade osteosarcoma include bizarrely arranged tumor cells, immature bone formation (osteoid), atypical fibroblasts    and infiltration of adjacent soft tissues. In our case the histopathological examination revealed a high grade osteoblastic type of osteosarcoma.
Clear surgical margins play a role in the eradication of the disease and limitation of intramedullary extension. However, due to the complexity of the anatomical location and proximity to vital structures, osteosarcomas arising from the maxilla are often more difficult to resect with a sufficiently safe margin. This is reflected by a relatively high local recurrence rate which is a major complication after surgical therapy, as presented in this case. Study by Delgado et al. suggested that when surgical margins are not free of disease, the use of radiation does not improve the outcome [8].
The recurrence in our case was noted within three years. In the study by Tabone et al., the median interval between the diagnosis of the primary osteosarcoma and the first recurrence was found to be 21 months. They concluded that the most important prognostic indicator at first recurrence seems to be the possible complete resection of disease. Patients not amenable to surgery and patients with a second or a third recurrence have a poor prognosis [9]. If surgical resection is not attempted or cannot be performed, progression of the disease can be fatal [10]. The overall a 5-year survival rate of osteosarcoma patients is found to be 62%. The ability to achieve initial complete removal of the lesion with clear surgical margins of greater than 5 mm is said to demonstrate a better survival, decreased recurrences and less metastasis than those with margins less than 5 mm [3].

cONcLUsION
Osteosarcoma affecting the maxilla is relatively rare condition when compared to those in the long bones. Anatomic limitations in the orofacial region cause difficulties in achieving uninvolved margins and for this reason local recurrence of the lesion is high. Superficial fungal infections can cause alterations in both clinical and histopathological presentation. A regular follow-up of the patients after maxillary osteosarcoma resection is advised to rule out further recurrence. *********

AN INTRODUCTION
Edorium Journals: On Web

About Edorium Journals
Edorium Journals is a publisher of high-quality, open access, international scholarly journals covering subjects in basic sciences and clinical specialties and subspecialties.

Edorium Journals: An introduction
Edorium Journals Team

But why should you publish with Edorium Journals?
In less than 10 words -we give you what no one does.

Vision of being the best
We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day of every week of every month of every year.

Exceptional services
We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this.

Editorial Review
All manuscripts submitted to Edorium Journals undergo pre-processing review, first editorial review, peer review, second editorial review and finally third editorial review.

Peer Review
All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review.

Early View version
Early View version of your manuscript will be published in the journal within 72 hours of final acceptance.

Manuscript status
From submission to publication of your article you will get regular updates (minimum six times) about status of your manuscripts directly in your email.

Most Favored Author program
Join this program and publish any number of articles free of charge for one to five years.

Favored Author program
One email is all it takes to become our favored author. You will not only get fee waivers but also get information and insights about scholarly publishing.

Institutional Membership program
Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in fees make their research accessible to all.

Our presence
We have some of the best designed publication formats. Our websites are very user friendly and enable you to do your work very easily with no hassle.

Something more...
We request you to have a look at our website to know more about us and our services.
We welcome you to interact with us, share with us, join us and of course publish with us.

Invitation for article submission
We sincerely invite you to submit your valuable research for publication to Edorium Journals.

Six weeks
You will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this by even one day, we will publish your manuscript free of charge.

Four weeks
After we receive page proofs, your manuscript will be published in the journal within four weeks (31 days). If we fail to honor this by even one day, we will publish your manuscript free of charge and refund you the full article publication charges you paid for your manuscript.